|

PRMT5 Inhibitor BMS-986504 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BMS 986504, BMS-986504, BMS986504, MRTX 1719, MRTX-1719 +5 more

Pipeline

Phase 1/2: 1

Top Sponsors

  • Northwestern University1

Indications

  • Metastatic Biliary Tract Carcinoma1
  • Metastatic Pancreatic Carcinoma1
  • Metastatic Malignant Digestive System Neoplasm1
  • Metastatic Esophageal Carcinoma1
  • Stage IV Colon Cancer AJCC v81

Chicago, Illinois1 trial

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

Northwestern University

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.